N-benzylcyclohexanecarboxamide

Catalog No.: 
ACIRYE122
CAS No.: 
35665-26-0
Molecular Formula: 
C14H19NO
Molecular Weight: 
217.15
N-benzylcyclohexanecarboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$65.00In stockInquiry
100mg95%$99.00In stockIn stock
250mg95%$141.00In stockIn stock
1g95%$419.00In stockIn stock
5g95%$1999.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-benzylcyclohexanecarboxamide
IUPAC NameN-benzylcyclohexanecarboxamide
MDL No.MFCD01355913
Molecular FormulaC14H19NO
Molecular Weight217.15
SMILESO=C(C1CCCCC1)NCC2=CC=CC=C2
InChI KeyKYIUKSZCASTDGQ-UHFFFAOYSA-N
SynonymCyclohexanecarboxamide, N-(phenylmethyl)-;N-(Phenylmethyl)cyclohexanecarboxamide
CAS No.35665-26-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACIRYE122 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACICYA027 route compound structure diagram
    ACICYA02737488-40-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIRYE122 route product structure diagram
    ACIRYE12235665-26-0In Stock
Inquiry

2. ACIRYE122 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACICYA027 route compound structure diagram
    ACICYA02737488-40-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIRYE122 route product structure diagram
    ACIRYE12235665-26-0In Stock
Inquiry

3. ACIRYE122 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIRYE122 route product structure diagram
    ACIRYE12235665-26-0In Stock
Inquiry

Comments (0)